Lyell Immunopharma (LYEL) EPS (Diluted) (2020 - 2026)
Powered by 
Analysis
Lyell Immunopharma (LYEL) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 0.15 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 10 | Lyell Immunopharma | 336.44 Mn | 336.44 Mn | - | -1.93 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.93 |
| Mar 31, 2026 | -1.92 |
| Dec 31, 2025 | -7.31 |
| Sep 30, 2025 | -1.86 |
| Jun 30, 2025 | -2.97 |
| Mar 31, 2025 | -3.63 |
| Dec 31, 2024 | -15.01 |
| Sep 30, 2024 | -3.48 |
| Jun 30, 2024 | -3.54 |
| Mar 31, 2024 | -3.84 |
| Dec 31, 2023 | -4.18 |
| Sep 30, 2023 | -4.17 |
| Jun 30, 2023 | -4.85 |
| Mar 31, 2023 | -4.65 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | -5.17 |
| Jun 30, 2022 | -3.17 |
| Mar 31, 2022 | -6.02 |
| Dec 31, 2021 | -7.40 |
| Sep 30, 2021 | -4.08 |